Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uterine Cervical Neoplasms × Misoprostol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 5 Myofibroma 5 Hemorrhage 4 Leiomyoma 3 Blood Loss, Surgical 3 Uterine Cervical Neoplasms 1 Myoma 1 Diabetes Insipidus 1

Interventions

Cisplatin 176 Paclitaxel 79 Radiotherapy 76 Carboplatin 70 Brachytherapy 69 pembrolizumab 64 Bevacizumab 40 Gemcitabine 28 Radiation 27 Topotecan 26 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 25 Colposcopy 22 human papillomavirus vaccine, L1 type 16, 18 21 Nivolumab 21 Magnetic Resonance Spectroscopy 20 atezolizumab 19 Platinum 19 Drug Therapy 19 Papillomavirus Vaccines 18 Radiotherapy, Intensity-Modulated 17 Docetaxel 17 Taxes 16 Cyclophosphamide 16 Biopsy 16 Early Intervention, Educational 15 1,2-diaminocyclohexaneplatinum II citrate 15 Methods 14 Blood Specimen Collection 14 fludarabine 13 Injections 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06669533 2025-10-01

MISOPCx

University of Alabama at Birmingham

Phase NA Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡